Caxton Associates (New York)’s SpartanNash SPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$592K Buy
32,306
+1,599
+5% +$31.9K 0.02% 300
2024
Q3
$688K Buy
30,707
+12,257
+66% +$253K 0.03% 313
2024
Q2
$346K Sell
18,450
-3,851
-17% -$75.1K 0.01% 389
2024
Q1
$451K Buy
22,301
+8,901
+66% +$192K 0.03% 337
2023
Q4
$308K Buy
+13,400
New +$305K 0.02% 396
2019
Q4
Sell
-11,413
Closed -$135K 540
2019
Q3
$135K Sell
11,413
-14,444
-56% -$163K 0.03% 367
2019
Q2
$302K Buy
+25,857
New +$369K 0.04% 282

Other funds holding SPTN

Caxton Associates (New York)'s SPTN Position: Q4 2024 in Review

Caxton Associates (New York) increased its SpartanNash (SPTN) stake by 5.2% in Q4 2024, buying an estimated $31.9K and bringing the position to 32,306 shares worth $592K. The position accounts for 0.02% of the portfolio, ranked #300.

Caxton Associates (New York) first reported a position in SPTN in Q2 2019 and has held it in 7 quarters since. The position peaked at $688K in Q3 2024. 201 funds tracked by Wall St. Rank hold SPTN as of Q4 2024.

  • Caxton Associates (New York) held 32,306 shares of SpartanNash worth $592K as of Q4 2024.
  • Caxton Associates (New York) bought 1,599 SpartanNash shares in Q4 2024, an estimated $31.9K.
  • SpartanNash made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #300 holding.
  • Caxton Associates (New York) first reported a position in SpartanNash in Q2 2019 and has held it in 7 quarters since.
  • Caxton Associates (New York)'s SpartanNash position peaked at $688K in Q3 2024.
  • 201 funds tracked by Wall St. Rank held SpartanNash as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.